MNCs and Patent Applications: The Tip of the Iceberg and the Iceberg itself
According to a news item that featured today in the Business Standard, the Novartis and Roche controversies may just be the “tip of a huge iceberg.” According to the report: “358 of 413 drug patent applications for the disease in India are from top multinationals. A city-based policy research group has found that multinational drug firms have filed over 350 patent applications for drugs used in cancer treatment. An analysis of pharma patent applications pending with the patent office by […]
MNCs and Patent Applications: The Tip of the Iceberg and the Iceberg itself Read More »